TerminatedPhase 3

Surgical Breast Resection With or Without Axillary Lymph Node Excision in Treating Women With Breast Cancer

France625 participantsStarted 1995-09

Plain-language summary

This randomized phase III trial is studying surgery and axillary lymph node dissection to evaluate if systematic Axillary Lymph Node Excision can be avoided in locoregional treatment for operable breast cancer smaller than 10 mm among menopausal women older than 50

Who can participate

Age range50 Years – 100 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria: Women, 50 year or more Menopausal women Breast cancer Macroscopic tumor size of 10 mm or less (measured during operation) No palpable axillary node ( N0) Exclusion criteria: Previous cancer history life expectancy \< 10 years Metastasis

What they're measuring

Number of Deaths

Timeframe: Five years after surgery

Trial details

NCT IDNCT00210236

SponsorInstitut Bergonié

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2005-12

Results submitted2025-08-22

View on ClinicalTrials.gov More Breast Cancer trials